STAT January 8, 2020
Rebecca Robbins

In 2016, the biotech billionaire Dr. Patrick Soon-Shiong set himself a deadline: By 2020, he would transform the fight against cancer.

With the help of a coalition of big-name companies, researchers, and physicians, Soon-Shiong vowed, he would enroll 20,000 cancer patients in clinical trials and develop an effective vaccine to treat the disease.

Four years later, independent medical researchers say they’ve heard virtual radio silence from Soon-Shiong’s initiative. And a review by STAT of clinical trial listings, research presentations, and press releases suggests the effort has fallen far short of its major goals.

Soon-Shiong and his team plan to “release results” next week related to his Cancer Breakthroughs 2020 initiative, according to his spokesperson, Jen Hodson. The announcement will take...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Precision Medicine, Provider, Technology
Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine
BioAro Announces Real Time DNA Decoding Technology
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future

Share This Article